Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
38 results
D2.33 - Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough
D2.34 - Generalized allergic contact dermatitis: a case report
D2.35 - Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation
D2.36 - Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema
D2.37 - Prevalence of food cross-sensitization due to PR-10 proteins among patients of different age groups
D2.38 - Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy
D2.39 - Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test
D2.42 - Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy
D2.43 - Implementation of the New Italian Health Care Price List: Impact on Allergy Diagnostics
D2.44 - Kiwi Allergy in Singaporean Children
D2.45 - Specific IgE for inhalant allergens: A cutoff of 0.35 kUA/L is too low
D2.46 - Prevalence and prognosis of food allergies after liver transplantation in children
D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria
D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117
D2.354 - Questionnaire survey of new treatments for atopic dermatitis
D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria
D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria
D2.357 - Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience
D2.358 - Immune shift toward the IL-17 pathway: A case of paradoxical psoriasis in a patient with severe atopic dermatitis induced by dupilumab
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download